The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
28th Aug 20147:00 amRNSBoard Appointment and Acquisition
17th Jul 201410:46 amRNSTransaction in Own Securities, Total Voting Rights
15th Jul 20147:00 amRNSTrading Update
28th Apr 20147:00 amRNSSignificant Contract Win
16th Apr 20145:00 pmRNSBlocklisting Interim Review
11th Apr 201412:05 pmRNSDirector/PDMR Shareholding
4th Apr 20144:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20147:00 amRNSSignificant Contract Wins
31st Mar 20142:29 pmRNSDividend Currency Election
11th Mar 20147:00 amRNSHalf Yearly Report
16th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20134:57 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSDividend Currency Election
12th Nov 20135:52 pmRNSResult of AGM
12th Nov 20137:00 amRNSAGM Statement and Appointment
18th Oct 20131:57 pmRNSPosting of Annual Report, Notice of AGM
30th Sep 20132:20 pmRNSHolding(s) in Company
12th Sep 20136:25 pmRNSDirector/PDMR Shareholding
11th Sep 20134:40 pmRNSDirector/PDMR Shareholding
11th Sep 20138:50 amRNSGrant of Options
10th Sep 20137:00 amRNSFinal Results
12th Jul 20137:00 amRNSNotice of Results
26th Jun 20137:00 amRNSTrading Update
15th Apr 201311:09 amRNSBlocklisting Interim Review
12th Apr 20135:32 pmRNSTotal Voting Rights
18th Mar 20133:30 pmRNSDividend Currency Election
4th Mar 20134:29 pmRNSTotal Voting Rights
27th Feb 201312:29 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSHalf Yearly Report
15th Feb 201312:00 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSTrading Update
30th Nov 201212:41 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSDividend Currency Election
8th Nov 201211:45 amRNSResult of AGM
8th Nov 20128:00 amRNSAGM Statement
19th Oct 201212:54 pmRNSBlocklisting Interim Review
10th Oct 20125:32 pmRNSPosting of Annual Report & Notice of AGM
24th Sep 20125:22 pmRNSGrant of Options
19th Sep 20125:53 pmRNSHolding(s) in Company
17th Sep 201211:38 amRNSDirector/PDMR Shareholding
6th Sep 201211:35 amRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.